Detalhe da pesquisa
1.
Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Int J Cancer
; 136(5): 1234-40, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25042739
2.
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
Oncologist
; 19(5): 562-7, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24710308
3.
Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.
Cancer Immunol Immunother
; 63(2): 161-74, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24233342
4.
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.
Int J Cancer
; 133(5): 1253-8, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23404208
5.
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Int J Cancer
; 133(2): 373-82, 2013 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23319273
6.
Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer.
Oncologist
; 18(7): 821-2, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23847257
7.
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 13(5): 501-8, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22326924
8.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37260975
9.
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
Cancer Immunol Immunother
; 60(2): 197-206, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20976449
10.
The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring.
J Biomed Biotechnol
; 2011: 182413, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21318157
11.
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
Cancer Immunol Immunother
; 59(5): 663-74, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19890632
12.
Strategies for cancer vaccine development.
J Biomed Biotechnol
; 20102010.
Artigo
Inglês
| MEDLINE | ID: mdl-20706612
13.
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.
Mol Cell Endocrinol
; 264(1-2): 44-9, 2007 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-17097220
14.
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
FASEB J
; 20(10): 1709-11, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16809434
15.
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer.
Curr Med Chem
; 24(12): 1170-1185, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28093985
16.
Corticotropin-releasing hormone receptor-1 in human endometrial cancer.
Oncol Rep
; 15(2): 375-9, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16391857
17.
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide.
Eur J Cancer
; 41(18): 2948-57, 2005 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16288862
18.
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.
Int J Oncol
; 27(2): 525-35, 2005 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16010436
19.
Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.
Int J Oncol
; 26(2): 415-22, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15645126
20.
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
Clin Cancer Res
; 9(14): 5370-9, 2003 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14614022